nodes	percent_of_prediction	percent_of_DWPC	metapath
Isoprenaline—ADRBK1—rheumatoid arthritis	0.71	1	CbGaD
Isoprenaline—PIK3R2—digestive system—rheumatoid arthritis	0.00235	0.139	CbGeAlD
Isoprenaline—PIK3R1—parotid gland—rheumatoid arthritis	0.00214	0.126	CbGeAlD
Isoprenaline—PIK3R1—saliva-secreting gland—rheumatoid arthritis	0.00205	0.121	CbGeAlD
Isoprenaline—PIK3R3—tendon—rheumatoid arthritis	0.00152	0.0895	CbGeAlD
Isoprenaline—ADRB3—connective tissue—rheumatoid arthritis	0.00133	0.0788	CbGeAlD
Isoprenaline—PIK3R1—tendon—rheumatoid arthritis	0.00129	0.0765	CbGeAlD
Isoprenaline—MAPK1—connective tissue—rheumatoid arthritis	0.00128	0.0759	CbGeAlD
Isoprenaline—ADRBK1—lymphoid tissue—rheumatoid arthritis	0.000953	0.0563	CbGeAlD
Isoprenaline—Masoprocol—ALOX5—rheumatoid arthritis	0.000949	0.452	CrCbGaD
Isoprenaline—Epinephrine—ADRBK1—rheumatoid arthritis	0.000946	0.451	CrCbGaD
Isoprenaline—ADRBK1—digestive system—rheumatoid arthritis	0.000941	0.0556	CbGeAlD
Isoprenaline—MAPK1—lymphoid tissue—rheumatoid arthritis	0.000939	0.0555	CbGeAlD
Isoprenaline—MAPK1—digestive system—rheumatoid arthritis	0.000928	0.0548	CbGeAlD
Isoprenaline—Pallor—Leflunomide—rheumatoid arthritis	0.00069	0.0282	CcSEcCtD
Isoprenaline—Hypertension—Ergocalciferol—rheumatoid arthritis	0.000583	0.0239	CcSEcCtD
Isoprenaline—ADRB1—connective tissue—rheumatoid arthritis	0.000545	0.0322	CbGeAlD
Isoprenaline—CYP1A1—parotid gland—rheumatoid arthritis	0.0004	0.0236	CbGeAlD
Isoprenaline—Asthenia—Ergocalciferol—rheumatoid arthritis	0.000396	0.0162	CcSEcCtD
Isoprenaline—Pulmonary oedema—Prednisolone—rheumatoid arthritis	0.000358	0.0146	CcSEcCtD
Isoprenaline—Angina pectoris—Leflunomide—rheumatoid arthritis	0.00035	0.0143	CcSEcCtD
Isoprenaline—Pulmonary oedema—Hydrocortisone—rheumatoid arthritis	0.000349	0.0143	CcSEcCtD
Isoprenaline—Pulmonary oedema—Triamcinolone—rheumatoid arthritis	0.000329	0.0135	CcSEcCtD
Isoprenaline—Pulmonary oedema—Methylprednisolone—rheumatoid arthritis	0.000328	0.0134	CcSEcCtD
Isoprenaline—Nausea—Ergocalciferol—rheumatoid arthritis	0.000327	0.0134	CcSEcCtD
Isoprenaline—Pulmonary oedema—Betamethasone—rheumatoid arthritis	0.000298	0.0122	CcSEcCtD
Isoprenaline—Pulmonary oedema—Dexamethasone—rheumatoid arthritis	0.000298	0.0122	CcSEcCtD
Isoprenaline—Cardiac arrest—Prednisolone—rheumatoid arthritis	0.000277	0.0113	CcSEcCtD
Isoprenaline—Bronchospasm—Cyclosporine—rheumatoid arthritis	0.000272	0.0111	CcSEcCtD
Isoprenaline—Arrhythmia—Azathioprine—rheumatoid arthritis	0.000272	0.0111	CcSEcCtD
Isoprenaline—Cardiac arrest—Hydrocortisone—rheumatoid arthritis	0.000271	0.0111	CcSEcCtD
Isoprenaline—Nausea—Auranofin—rheumatoid arthritis	0.000267	0.0109	CcSEcCtD
Isoprenaline—Pulmonary oedema—Prednisone—rheumatoid arthritis	0.00026	0.0106	CcSEcCtD
Isoprenaline—Arrhythmia—Leflunomide—rheumatoid arthritis	0.000257	0.0105	CcSEcCtD
Isoprenaline—Cardiac arrest—Triamcinolone—rheumatoid arthritis	0.000255	0.0104	CcSEcCtD
Isoprenaline—Cardiac arrest—Methylprednisolone—rheumatoid arthritis	0.000254	0.0104	CcSEcCtD
Isoprenaline—CYP1A1—digestive system—rheumatoid arthritis	0.000254	0.015	CbGeAlD
Isoprenaline—Nausea—Penicillamine—rheumatoid arthritis	0.000247	0.0101	CcSEcCtD
Isoprenaline—Vision blurred—Leflunomide—rheumatoid arthritis	0.000236	0.00964	CcSEcCtD
Isoprenaline—Cardiac arrest—Betamethasone—rheumatoid arthritis	0.000231	0.00947	CcSEcCtD
Isoprenaline—Cardiac arrest—Dexamethasone—rheumatoid arthritis	0.000231	0.00947	CcSEcCtD
Isoprenaline—Bronchospasm—Methylprednisolone—rheumatoid arthritis	0.000227	0.00931	CcSEcCtD
Isoprenaline—Vertigo—Leflunomide—rheumatoid arthritis	0.000225	0.00919	CcSEcCtD
Isoprenaline—Palpitations—Leflunomide—rheumatoid arthritis	0.000221	0.00904	CcSEcCtD
Isoprenaline—Pulmonary oedema—Methotrexate—rheumatoid arthritis	0.000217	0.00888	CcSEcCtD
Isoprenaline—Hypertension—Leflunomide—rheumatoid arthritis	0.000216	0.00883	CcSEcCtD
Isoprenaline—Flushing—Cyclosporine—rheumatoid arthritis	0.000206	0.00842	CcSEcCtD
Isoprenaline—Epinephrine—TNF—rheumatoid arthritis	0.000203	0.0967	CrCbGaD
Isoprenaline—Hypotension—Azathioprine—rheumatoid arthritis	0.000202	0.00826	CcSEcCtD
Isoprenaline—Cardiac arrest—Prednisone—rheumatoid arthritis	0.000201	0.00824	CcSEcCtD
Isoprenaline—Tachycardia—Leflunomide—rheumatoid arthritis	0.000199	0.00815	CcSEcCtD
Isoprenaline—Arrhythmia—Cyclosporine—rheumatoid arthritis	0.000198	0.0081	CcSEcCtD
Isoprenaline—Sweating—Methylprednisolone—rheumatoid arthritis	0.000198	0.00809	CcSEcCtD
Isoprenaline—Hyperhidrosis—Leflunomide—rheumatoid arthritis	0.000197	0.00807	CcSEcCtD
Isoprenaline—Hypotension—Leflunomide—rheumatoid arthritis	0.000191	0.0078	CcSEcCtD
Isoprenaline—Tension—Cyclosporine—rheumatoid arthritis	0.000189	0.00775	CcSEcCtD
Isoprenaline—Nervousness—Cyclosporine—rheumatoid arthritis	0.000187	0.00767	CcSEcCtD
Isoprenaline—Insomnia—Leflunomide—rheumatoid arthritis	0.000185	0.00755	CcSEcCtD
Isoprenaline—Dyspnoea—Leflunomide—rheumatoid arthritis	0.000182	0.00744	CcSEcCtD
Isoprenaline—Vision blurred—Cyclosporine—rheumatoid arthritis	0.000182	0.00744	CcSEcCtD
Isoprenaline—Tremor—Cyclosporine—rheumatoid arthritis	0.000181	0.0074	CcSEcCtD
Isoprenaline—Arrhythmia—Prednisolone—rheumatoid arthritis	0.00018	0.00737	CcSEcCtD
Isoprenaline—Arrhythmia—Hydrocortisone—rheumatoid arthritis	0.000176	0.0072	CcSEcCtD
Isoprenaline—Vertigo—Cyclosporine—rheumatoid arthritis	0.000173	0.00709	CcSEcCtD
Isoprenaline—Convulsion—Cyclosporine—rheumatoid arthritis	0.000167	0.00684	CcSEcCtD
Isoprenaline—Hypertension—Cyclosporine—rheumatoid arthritis	0.000167	0.00682	CcSEcCtD
Isoprenaline—Arrhythmia—Triamcinolone—rheumatoid arthritis	0.000166	0.00678	CcSEcCtD
Isoprenaline—Vision blurred—Prednisolone—rheumatoid arthritis	0.000165	0.00677	CcSEcCtD
Isoprenaline—Arrhythmia—Methylprednisolone—rheumatoid arthritis	0.000165	0.00677	CcSEcCtD
Isoprenaline—Vertigo—Prednisolone—rheumatoid arthritis	0.000158	0.00646	CcSEcCtD
Isoprenaline—Vertigo—Hydrocortisone—rheumatoid arthritis	0.000154	0.0063	CcSEcCtD
Isoprenaline—Hyperhidrosis—Cyclosporine—rheumatoid arthritis	0.000152	0.00623	CcSEcCtD
Isoprenaline—Convulsion—Prednisolone—rheumatoid arthritis	0.000152	0.00623	CcSEcCtD
Isoprenaline—Hypertension—Prednisolone—rheumatoid arthritis	0.000152	0.0062	CcSEcCtD
Isoprenaline—Arrhythmia—Betamethasone—rheumatoid arthritis	0.00015	0.00615	CcSEcCtD
Isoprenaline—Arrhythmia—Dexamethasone—rheumatoid arthritis	0.00015	0.00615	CcSEcCtD
Isoprenaline—Convulsion—Hydrocortisone—rheumatoid arthritis	0.000149	0.00608	CcSEcCtD
Isoprenaline—Hypertension—Hydrocortisone—rheumatoid arthritis	0.000148	0.00606	CcSEcCtD
Isoprenaline—Asthenia—Leflunomide—rheumatoid arthritis	0.000146	0.00599	CcSEcCtD
Isoprenaline—Vertigo—Triamcinolone—rheumatoid arthritis	0.000145	0.00594	CcSEcCtD
Isoprenaline—Vertigo—Methylprednisolone—rheumatoid arthritis	0.000145	0.00592	CcSEcCtD
Isoprenaline—Dizziness—Azathioprine—rheumatoid arthritis	0.000143	0.00585	CcSEcCtD
Isoprenaline—Insomnia—Cyclosporine—rheumatoid arthritis	0.000142	0.00583	CcSEcCtD
Isoprenaline—Dyspnoea—Cyclosporine—rheumatoid arthritis	0.00014	0.00574	CcSEcCtD
Isoprenaline—Convulsion—Triamcinolone—rheumatoid arthritis	0.00014	0.00572	CcSEcCtD
Isoprenaline—Tachycardia—Prednisolone—rheumatoid arthritis	0.00014	0.00572	CcSEcCtD
Isoprenaline—Convulsion—Methylprednisolone—rheumatoid arthritis	0.00014	0.00571	CcSEcCtD
Isoprenaline—Hypertension—Triamcinolone—rheumatoid arthritis	0.000139	0.0057	CcSEcCtD
Isoprenaline—Hypertension—Methylprednisolone—rheumatoid arthritis	0.000139	0.00569	CcSEcCtD
Isoprenaline—Hyperhidrosis—Prednisolone—rheumatoid arthritis	0.000139	0.00567	CcSEcCtD
Isoprenaline—Tachycardia—Hydrocortisone—rheumatoid arthritis	0.000137	0.00559	CcSEcCtD
Isoprenaline—Flushing—Prednisone—rheumatoid arthritis	0.000136	0.00557	CcSEcCtD
Isoprenaline—Headache—Azathioprine—rheumatoid arthritis	0.000135	0.00554	CcSEcCtD
Isoprenaline—Hyperhidrosis—Hydrocortisone—rheumatoid arthritis	0.000135	0.00554	CcSEcCtD
Isoprenaline—Dizziness—Leflunomide—rheumatoid arthritis	0.000135	0.00552	CcSEcCtD
Isoprenaline—Vertigo—Dexamethasone—rheumatoid arthritis	0.000132	0.00539	CcSEcCtD
Isoprenaline—Vertigo—Betamethasone—rheumatoid arthritis	0.000132	0.00539	CcSEcCtD
Isoprenaline—Arrhythmia—Prednisone—rheumatoid arthritis	0.000131	0.00536	CcSEcCtD
Isoprenaline—Sweating—Methotrexate—rheumatoid arthritis	0.000131	0.00535	CcSEcCtD
Isoprenaline—Hypotension—Hydrocortisone—rheumatoid arthritis	0.000131	0.00535	CcSEcCtD
Isoprenaline—Insomnia—Prednisolone—rheumatoid arthritis	0.00013	0.0053	CcSEcCtD
Isoprenaline—Tachycardia—Triamcinolone—rheumatoid arthritis	0.000129	0.00526	CcSEcCtD
Isoprenaline—Nausea—Azathioprine—rheumatoid arthritis	0.000128	0.00525	CcSEcCtD
Isoprenaline—Tachycardia—Methylprednisolone—rheumatoid arthritis	0.000128	0.00525	CcSEcCtD
Isoprenaline—Headache—Leflunomide—rheumatoid arthritis	0.000128	0.00523	CcSEcCtD
Isoprenaline—Hyperhidrosis—Triamcinolone—rheumatoid arthritis	0.000127	0.00521	CcSEcCtD
Isoprenaline—Hyperhidrosis—Methylprednisolone—rheumatoid arthritis	0.000127	0.0052	CcSEcCtD
Isoprenaline—Convulsion—Dexamethasone—rheumatoid arthritis	0.000127	0.00519	CcSEcCtD
Isoprenaline—Convulsion—Betamethasone—rheumatoid arthritis	0.000127	0.00519	CcSEcCtD
Isoprenaline—Insomnia—Hydrocortisone—rheumatoid arthritis	0.000127	0.00518	CcSEcCtD
Isoprenaline—Hypertension—Betamethasone—rheumatoid arthritis	0.000126	0.00518	CcSEcCtD
Isoprenaline—Hypertension—Dexamethasone—rheumatoid arthritis	0.000126	0.00518	CcSEcCtD
Isoprenaline—Hypotension—Methylprednisolone—rheumatoid arthritis	0.000123	0.00503	CcSEcCtD
Isoprenaline—Nausea—Leflunomide—rheumatoid arthritis	0.000121	0.00496	CcSEcCtD
Isoprenaline—Vision blurred—Prednisone—rheumatoid arthritis	0.00012	0.00492	CcSEcCtD
Isoprenaline—Insomnia—Triamcinolone—rheumatoid arthritis	0.000119	0.00488	CcSEcCtD
Isoprenaline—Insomnia—Methylprednisolone—rheumatoid arthritis	0.000119	0.00487	CcSEcCtD
Isoprenaline—Dyspnoea—Triamcinolone—rheumatoid arthritis	0.000117	0.00481	CcSEcCtD
Isoprenaline—Tachycardia—Dexamethasone—rheumatoid arthritis	0.000117	0.00478	CcSEcCtD
Isoprenaline—Tachycardia—Betamethasone—rheumatoid arthritis	0.000117	0.00478	CcSEcCtD
Isoprenaline—Hyperhidrosis—Dexamethasone—rheumatoid arthritis	0.000116	0.00473	CcSEcCtD
Isoprenaline—Hyperhidrosis—Betamethasone—rheumatoid arthritis	0.000116	0.00473	CcSEcCtD
Isoprenaline—Vertigo—Prednisone—rheumatoid arthritis	0.000115	0.00469	CcSEcCtD
Isoprenaline—Asthenia—Cyclosporine—rheumatoid arthritis	0.000113	0.00462	CcSEcCtD
Isoprenaline—Hypotension—Dexamethasone—rheumatoid arthritis	0.000112	0.00457	CcSEcCtD
Isoprenaline—Hypotension—Betamethasone—rheumatoid arthritis	0.000112	0.00457	CcSEcCtD
Isoprenaline—Convulsion—Prednisone—rheumatoid arthritis	0.000111	0.00452	CcSEcCtD
Isoprenaline—Hypertension—Prednisone—rheumatoid arthritis	0.00011	0.00451	CcSEcCtD
Isoprenaline—Insomnia—Dexamethasone—rheumatoid arthritis	0.000108	0.00443	CcSEcCtD
Isoprenaline—Insomnia—Betamethasone—rheumatoid arthritis	0.000108	0.00443	CcSEcCtD
Isoprenaline—Dizziness—Cyclosporine—rheumatoid arthritis	0.000104	0.00426	CcSEcCtD
Isoprenaline—Tachycardia—Prednisone—rheumatoid arthritis	0.000102	0.00416	CcSEcCtD
Isoprenaline—Hyperhidrosis—Prednisone—rheumatoid arthritis	0.000101	0.00412	CcSEcCtD
Isoprenaline—Vision blurred—Methotrexate—rheumatoid arthritis	0.0001	0.00411	CcSEcCtD
Isoprenaline—Asthenia—Hydrocortisone—rheumatoid arthritis	0.0001	0.00411	CcSEcCtD
Isoprenaline—Headache—Cyclosporine—rheumatoid arthritis	9.87e-05	0.00404	CcSEcCtD
Isoprenaline—Vertigo—Methotrexate—rheumatoid arthritis	9.58e-05	0.00392	CcSEcCtD
Isoprenaline—Dizziness—Prednisolone—rheumatoid arthritis	9.48e-05	0.00388	CcSEcCtD
Isoprenaline—Asthenia—Triamcinolone—rheumatoid arthritis	9.46e-05	0.00387	CcSEcCtD
Isoprenaline—Asthenia—Methylprednisolone—rheumatoid arthritis	9.43e-05	0.00386	CcSEcCtD
Isoprenaline—Insomnia—Prednisone—rheumatoid arthritis	9.42e-05	0.00385	CcSEcCtD
Isoprenaline—Nausea—Cyclosporine—rheumatoid arthritis	9.35e-05	0.00383	CcSEcCtD
Isoprenaline—Dizziness—Hydrocortisone—rheumatoid arthritis	9.26e-05	0.00379	CcSEcCtD
Isoprenaline—Convulsion—Methotrexate—rheumatoid arthritis	9.24e-05	0.00378	CcSEcCtD
Isoprenaline—Headache—Prednisolone—rheumatoid arthritis	8.98e-05	0.00367	CcSEcCtD
Isoprenaline—Headache—Hydrocortisone—rheumatoid arthritis	8.77e-05	0.00359	CcSEcCtD
Isoprenaline—Dizziness—Triamcinolone—rheumatoid arthritis	8.71e-05	0.00357	CcSEcCtD
Isoprenaline—Dizziness—Methylprednisolone—rheumatoid arthritis	8.7e-05	0.00356	CcSEcCtD
Isoprenaline—Asthenia—Dexamethasone—rheumatoid arthritis	8.58e-05	0.00351	CcSEcCtD
Isoprenaline—Asthenia—Betamethasone—rheumatoid arthritis	8.58e-05	0.00351	CcSEcCtD
Isoprenaline—Nausea—Prednisolone—rheumatoid arthritis	8.51e-05	0.00348	CcSEcCtD
Isoprenaline—Hyperhidrosis—Methotrexate—rheumatoid arthritis	8.41e-05	0.00344	CcSEcCtD
Isoprenaline—Nausea—Hydrocortisone—rheumatoid arthritis	8.31e-05	0.0034	CcSEcCtD
Isoprenaline—Headache—Triamcinolone—rheumatoid arthritis	8.26e-05	0.00338	CcSEcCtD
Isoprenaline—Headache—Methylprednisolone—rheumatoid arthritis	8.24e-05	0.00337	CcSEcCtD
Isoprenaline—Hypotension—Methotrexate—rheumatoid arthritis	8.13e-05	0.00333	CcSEcCtD
Isoprenaline—Dizziness—Dexamethasone—rheumatoid arthritis	7.91e-05	0.00324	CcSEcCtD
Isoprenaline—Dizziness—Betamethasone—rheumatoid arthritis	7.91e-05	0.00324	CcSEcCtD
Isoprenaline—Insomnia—Methotrexate—rheumatoid arthritis	7.87e-05	0.00322	CcSEcCtD
Isoprenaline—Nausea—Triamcinolone—rheumatoid arthritis	7.83e-05	0.0032	CcSEcCtD
Isoprenaline—Nausea—Methylprednisolone—rheumatoid arthritis	7.81e-05	0.0032	CcSEcCtD
Isoprenaline—Dyspnoea—Methotrexate—rheumatoid arthritis	7.76e-05	0.00317	CcSEcCtD
Isoprenaline—Headache—Betamethasone—rheumatoid arthritis	7.49e-05	0.00307	CcSEcCtD
Isoprenaline—Headache—Dexamethasone—rheumatoid arthritis	7.49e-05	0.00307	CcSEcCtD
Isoprenaline—Asthenia—Prednisone—rheumatoid arthritis	7.47e-05	0.00306	CcSEcCtD
Isoprenaline—Nausea—Dexamethasone—rheumatoid arthritis	7.1e-05	0.00291	CcSEcCtD
Isoprenaline—Nausea—Betamethasone—rheumatoid arthritis	7.1e-05	0.00291	CcSEcCtD
Isoprenaline—Dizziness—Prednisone—rheumatoid arthritis	6.89e-05	0.00282	CcSEcCtD
Isoprenaline—Headache—Prednisone—rheumatoid arthritis	6.52e-05	0.00267	CcSEcCtD
Isoprenaline—Asthenia—Methotrexate—rheumatoid arthritis	6.24e-05	0.00255	CcSEcCtD
Isoprenaline—Nausea—Prednisone—rheumatoid arthritis	6.19e-05	0.00253	CcSEcCtD
Isoprenaline—Dizziness—Methotrexate—rheumatoid arthritis	5.76e-05	0.00235	CcSEcCtD
Isoprenaline—Headache—Methotrexate—rheumatoid arthritis	5.45e-05	0.00223	CcSEcCtD
Isoprenaline—Nausea—Methotrexate—rheumatoid arthritis	5.17e-05	0.00212	CcSEcCtD
Isoprenaline—ADRB2—Signaling Pathways—CD28—rheumatoid arthritis	4.12e-06	1.67e-05	CbGpPWpGaD
Isoprenaline—PIK3R3—Signaling Pathways—IL2—rheumatoid arthritis	4.12e-06	1.67e-05	CbGpPWpGaD
Isoprenaline—PIK3R1—Immune System—IL2—rheumatoid arthritis	4.12e-06	1.67e-05	CbGpPWpGaD
Isoprenaline—PIK3R1—Disease—PTGS2—rheumatoid arthritis	4.1e-06	1.66e-05	CbGpPWpGaD
Isoprenaline—PIK3R3—Signaling by GPCR—IL6—rheumatoid arthritis	4.1e-06	1.66e-05	CbGpPWpGaD
Isoprenaline—MAPK1—Signaling Pathways—STAT1—rheumatoid arthritis	4.09e-06	1.66e-05	CbGpPWpGaD
Isoprenaline—ADRB3—Signaling Pathways—LEP—rheumatoid arthritis	4.09e-06	1.66e-05	CbGpPWpGaD
Isoprenaline—MAPK1—Signaling by GPCR—CCL2—rheumatoid arthritis	4.05e-06	1.64e-05	CbGpPWpGaD
Isoprenaline—MAPK1—Signaling by GPCR—IL6R—rheumatoid arthritis	4.04e-06	1.64e-05	CbGpPWpGaD
Isoprenaline—MAPK1—Signaling Pathways—CXCL10—rheumatoid arthritis	4.04e-06	1.64e-05	CbGpPWpGaD
Isoprenaline—MAPK1—Immune System—CD80—rheumatoid arthritis	3.98e-06	1.62e-05	CbGpPWpGaD
Isoprenaline—ADRB1—Signaling Pathways—UBE2D1—rheumatoid arthritis	3.97e-06	1.61e-05	CbGpPWpGaD
Isoprenaline—MAPK1—Developmental Biology—TNF—rheumatoid arthritis	3.96e-06	1.61e-05	CbGpPWpGaD
Isoprenaline—PIK3R1—Signaling Pathways—FN1—rheumatoid arthritis	3.95e-06	1.6e-05	CbGpPWpGaD
Isoprenaline—PIK3R2—Signaling Pathways—TYK2—rheumatoid arthritis	3.95e-06	1.6e-05	CbGpPWpGaD
Isoprenaline—PIK3R1—Signaling Pathways—IL6ST—rheumatoid arthritis	3.94e-06	1.6e-05	CbGpPWpGaD
Isoprenaline—PIK3R1—Metabolism—ALB—rheumatoid arthritis	3.92e-06	1.59e-05	CbGpPWpGaD
Isoprenaline—PIK3R3—Signaling Pathways—MMP9—rheumatoid arthritis	3.9e-06	1.58e-05	CbGpPWpGaD
Isoprenaline—ADRB1—Signaling Pathways—CXCL12—rheumatoid arthritis	3.89e-06	1.58e-05	CbGpPWpGaD
Isoprenaline—ADRB1—Signaling Pathways—BDKRB2—rheumatoid arthritis	3.89e-06	1.58e-05	CbGpPWpGaD
Isoprenaline—ADRBK1—Signaling Pathways—TYK2—rheumatoid arthritis	3.89e-06	1.58e-05	CbGpPWpGaD
Isoprenaline—ADRB1—GPCR downstream signaling—POMC—rheumatoid arthritis	3.89e-06	1.58e-05	CbGpPWpGaD
Isoprenaline—ADRB2—Signaling Pathways—UBE2D1—rheumatoid arthritis	3.88e-06	1.57e-05	CbGpPWpGaD
Isoprenaline—PIK3R2—Signaling Pathways—NOS3—rheumatoid arthritis	3.87e-06	1.57e-05	CbGpPWpGaD
Isoprenaline—ADRB1—Signaling by GPCR—IL6ST—rheumatoid arthritis	3.86e-06	1.57e-05	CbGpPWpGaD
Isoprenaline—PIK3R3—Signaling Pathways—NFKB1—rheumatoid arthritis	3.86e-06	1.56e-05	CbGpPWpGaD
Isoprenaline—ADRB3—Signaling Pathways—FN1—rheumatoid arthritis	3.86e-06	1.56e-05	CbGpPWpGaD
Isoprenaline—PIK3R1—Immune System—NFKB1—rheumatoid arthritis	3.85e-06	1.56e-05	CbGpPWpGaD
Isoprenaline—ADRB1—Signaling Pathways—ADRBK1—rheumatoid arthritis	3.85e-06	1.56e-05	CbGpPWpGaD
Isoprenaline—ADRB3—Signaling Pathways—IL6ST—rheumatoid arthritis	3.84e-06	1.56e-05	CbGpPWpGaD
Isoprenaline—MAPK1—Disease—IL6ST—rheumatoid arthritis	3.82e-06	1.55e-05	CbGpPWpGaD
Isoprenaline—ADRBK1—Signaling Pathways—NOS3—rheumatoid arthritis	3.82e-06	1.55e-05	CbGpPWpGaD
Isoprenaline—ADRB2—Signaling Pathways—BDKRB2—rheumatoid arthritis	3.81e-06	1.54e-05	CbGpPWpGaD
Isoprenaline—ADRB2—Signaling Pathways—CXCL12—rheumatoid arthritis	3.81e-06	1.54e-05	CbGpPWpGaD
Isoprenaline—ADRB2—GPCR downstream signaling—POMC—rheumatoid arthritis	3.8e-06	1.54e-05	CbGpPWpGaD
Isoprenaline—PIK3R3—Signaling Pathways—MAPK8—rheumatoid arthritis	3.79e-06	1.54e-05	CbGpPWpGaD
Isoprenaline—MAPK1—Disease—NOS2—rheumatoid arthritis	3.79e-06	1.54e-05	CbGpPWpGaD
Isoprenaline—PIK3R1—Immune System—MAPK8—rheumatoid arthritis	3.79e-06	1.54e-05	CbGpPWpGaD
Isoprenaline—PIK3R1—Signaling Pathways—CD80—rheumatoid arthritis	3.79e-06	1.54e-05	CbGpPWpGaD
Isoprenaline—ADRB2—Signaling by GPCR—IL6ST—rheumatoid arthritis	3.78e-06	1.53e-05	CbGpPWpGaD
Isoprenaline—ADRB2—Signaling Pathways—ADRBK1—rheumatoid arthritis	3.77e-06	1.53e-05	CbGpPWpGaD
Isoprenaline—PIK3R1—Metabolism—NOS3—rheumatoid arthritis	3.75e-06	1.52e-05	CbGpPWpGaD
Isoprenaline—PIK3R3—Immune System—IL6—rheumatoid arthritis	3.75e-06	1.52e-05	CbGpPWpGaD
Isoprenaline—ADRB3—Signaling Pathways—CD80—rheumatoid arthritis	3.7e-06	1.5e-05	CbGpPWpGaD
Isoprenaline—MAPK1—Immune System—IL6R—rheumatoid arthritis	3.69e-06	1.5e-05	CbGpPWpGaD
Isoprenaline—MAPK1—Signaling Pathways—MMP3—rheumatoid arthritis	3.68e-06	1.49e-05	CbGpPWpGaD
Isoprenaline—MAPK1—Signaling by GPCR—TYK2—rheumatoid arthritis	3.68e-06	1.49e-05	CbGpPWpGaD
Isoprenaline—MAPK1—Disease—CD80—rheumatoid arthritis	3.68e-06	1.49e-05	CbGpPWpGaD
Isoprenaline—PIK3R2—Disease—TGFB1—rheumatoid arthritis	3.66e-06	1.48e-05	CbGpPWpGaD
Isoprenaline—CYP1A1—Metabolism of lipids and lipoproteins—POMC—rheumatoid arthritis	3.64e-06	1.48e-05	CbGpPWpGaD
Isoprenaline—ADRB1—Signaling Pathways—RASGRP1—rheumatoid arthritis	3.63e-06	1.47e-05	CbGpPWpGaD
Isoprenaline—ADRB1—Signaling Pathways—SYK—rheumatoid arthritis	3.62e-06	1.47e-05	CbGpPWpGaD
Isoprenaline—ADRBK1—Disease—TGFB1—rheumatoid arthritis	3.6e-06	1.46e-05	CbGpPWpGaD
Isoprenaline—PIK3R1—Signaling Pathways—POMC—rheumatoid arthritis	3.6e-06	1.46e-05	CbGpPWpGaD
Isoprenaline—ADRB1—Signaling Pathways—PRKCQ—rheumatoid arthritis	3.55e-06	1.44e-05	CbGpPWpGaD
Isoprenaline—ADRB2—Signaling Pathways—RASGRP1—rheumatoid arthritis	3.55e-06	1.44e-05	CbGpPWpGaD
Isoprenaline—MAPK1—Signaling Pathways—PTK2—rheumatoid arthritis	3.54e-06	1.44e-05	CbGpPWpGaD
Isoprenaline—ADRB2—Signaling Pathways—SYK—rheumatoid arthritis	3.54e-06	1.44e-05	CbGpPWpGaD
Isoprenaline—ADRB1—Signaling by GPCR—POMC—rheumatoid arthritis	3.53e-06	1.43e-05	CbGpPWpGaD
Isoprenaline—PIK3R1—Signaling Pathways—CCL2—rheumatoid arthritis	3.52e-06	1.43e-05	CbGpPWpGaD
Isoprenaline—ADRB3—Signaling Pathways—POMC—rheumatoid arthritis	3.51e-06	1.42e-05	CbGpPWpGaD
Isoprenaline—PIK3R1—Signaling Pathways—IL6R—rheumatoid arthritis	3.51e-06	1.42e-05	CbGpPWpGaD
Isoprenaline—PIK3R3—Signaling Pathways—VEGFA—rheumatoid arthritis	3.5e-06	1.42e-05	CbGpPWpGaD
Isoprenaline—ADRB1—Signaling Pathways—STAT1—rheumatoid arthritis	3.49e-06	1.42e-05	CbGpPWpGaD
Isoprenaline—ADRB2—Signaling Pathways—PRKCQ—rheumatoid arthritis	3.48e-06	1.41e-05	CbGpPWpGaD
Isoprenaline—MAPK1—Signaling Pathways—CCL5—rheumatoid arthritis	3.48e-06	1.41e-05	CbGpPWpGaD
Isoprenaline—PIK3R3—Disease—IL6—rheumatoid arthritis	3.46e-06	1.4e-05	CbGpPWpGaD
Isoprenaline—ADRB1—Signaling by GPCR—CCL2—rheumatoid arthritis	3.45e-06	1.4e-05	CbGpPWpGaD
Isoprenaline—ADRB2—Signaling by GPCR—POMC—rheumatoid arthritis	3.45e-06	1.4e-05	CbGpPWpGaD
Isoprenaline—ADRB1—Signaling by GPCR—IL6R—rheumatoid arthritis	3.44e-06	1.4e-05	CbGpPWpGaD
Isoprenaline—ADRB1—Signaling Pathways—CXCL10—rheumatoid arthritis	3.44e-06	1.4e-05	CbGpPWpGaD
Isoprenaline—ADRB3—Signaling Pathways—CCL2—rheumatoid arthritis	3.44e-06	1.39e-05	CbGpPWpGaD
Isoprenaline—PIK3R2—Signaling Pathways—CXCL8—rheumatoid arthritis	3.44e-06	1.39e-05	CbGpPWpGaD
Isoprenaline—PIK3R1—Metabolism—PTGS2—rheumatoid arthritis	3.43e-06	1.39e-05	CbGpPWpGaD
Isoprenaline—ADRB3—Signaling Pathways—IL6R—rheumatoid arthritis	3.43e-06	1.39e-05	CbGpPWpGaD
Isoprenaline—MAPK1—Hemostasis—TP53—rheumatoid arthritis	3.43e-06	1.39e-05	CbGpPWpGaD
Isoprenaline—MAPK1—Signaling Pathways—CSF2—rheumatoid arthritis	3.42e-06	1.39e-05	CbGpPWpGaD
Isoprenaline—ADRB2—Signaling Pathways—STAT1—rheumatoid arthritis	3.41e-06	1.38e-05	CbGpPWpGaD
Isoprenaline—MAPK1—Disease—IL6R—rheumatoid arthritis	3.41e-06	1.38e-05	CbGpPWpGaD
Isoprenaline—ADRBK1—Signaling Pathways—CXCL8—rheumatoid arthritis	3.39e-06	1.37e-05	CbGpPWpGaD
Isoprenaline—ADRB2—Signaling by GPCR—CCL2—rheumatoid arthritis	3.38e-06	1.37e-05	CbGpPWpGaD
Isoprenaline—CYP1A1—Metabolism—ENO1—rheumatoid arthritis	3.38e-06	1.37e-05	CbGpPWpGaD
Isoprenaline—ADRB2—Signaling by GPCR—IL6R—rheumatoid arthritis	3.37e-06	1.37e-05	CbGpPWpGaD
Isoprenaline—ADRB2—Signaling Pathways—CXCL10—rheumatoid arthritis	3.37e-06	1.36e-05	CbGpPWpGaD
Isoprenaline—MAPK1—Immune System—TYK2—rheumatoid arthritis	3.36e-06	1.36e-05	CbGpPWpGaD
Isoprenaline—CYP1A1—Metabolism of lipids and lipoproteins—ALB—rheumatoid arthritis	3.32e-06	1.35e-05	CbGpPWpGaD
Isoprenaline—PIK3R2—Signaling Pathways—IL2—rheumatoid arthritis	3.28e-06	1.33e-05	CbGpPWpGaD
Isoprenaline—PIK3R2—Signaling by GPCR—IL6—rheumatoid arthritis	3.27e-06	1.33e-05	CbGpPWpGaD
Isoprenaline—ADRBK1—Signaling Pathways—IL2—rheumatoid arthritis	3.24e-06	1.31e-05	CbGpPWpGaD
Isoprenaline—MAPK1—Cell Cycle—TP53—rheumatoid arthritis	3.23e-06	1.31e-05	CbGpPWpGaD
Isoprenaline—ADRBK1—Signaling by GPCR—IL6—rheumatoid arthritis	3.22e-06	1.31e-05	CbGpPWpGaD
Isoprenaline—MAPK1—Signaling Pathways—SPP1—rheumatoid arthritis	3.22e-06	1.31e-05	CbGpPWpGaD
Isoprenaline—PIK3R3—Signaling Pathways—TGFB1—rheumatoid arthritis	3.21e-06	1.3e-05	CbGpPWpGaD
Isoprenaline—MAPK1—Signaling by GPCR—CXCL8—rheumatoid arthritis	3.2e-06	1.3e-05	CbGpPWpGaD
Isoprenaline—PIK3R1—Signaling Pathways—TYK2—rheumatoid arthritis	3.2e-06	1.3e-05	CbGpPWpGaD
Isoprenaline—MAPK1—Developmental Biology—IL6—rheumatoid arthritis	3.2e-06	1.3e-05	CbGpPWpGaD
Isoprenaline—MAPK1—Immune System—IFNG—rheumatoid arthritis	3.15e-06	1.28e-05	CbGpPWpGaD
Isoprenaline—PIK3R1—Signaling Pathways—NOS3—rheumatoid arthritis	3.14e-06	1.27e-05	CbGpPWpGaD
Isoprenaline—ADRB1—Signaling Pathways—MMP3—rheumatoid arthritis	3.14e-06	1.27e-05	CbGpPWpGaD
Isoprenaline—ADRB1—Signaling by GPCR—TYK2—rheumatoid arthritis	3.14e-06	1.27e-05	CbGpPWpGaD
Isoprenaline—MAPK1—Signaling Pathways—CCR5—rheumatoid arthritis	3.13e-06	1.27e-05	CbGpPWpGaD
Isoprenaline—ADRB3—Signaling Pathways—TYK2—rheumatoid arthritis	3.12e-06	1.27e-05	CbGpPWpGaD
Isoprenaline—PIK3R2—Signaling Pathways—MMP9—rheumatoid arthritis	3.11e-06	1.26e-05	CbGpPWpGaD
Isoprenaline—MAPK1—Disease—TYK2—rheumatoid arthritis	3.1e-06	1.26e-05	CbGpPWpGaD
Isoprenaline—MAPK1—Signaling Pathways—IL2RA—rheumatoid arthritis	3.09e-06	1.25e-05	CbGpPWpGaD
Isoprenaline—PIK3R2—Signaling Pathways—NFKB1—rheumatoid arthritis	3.08e-06	1.25e-05	CbGpPWpGaD
Isoprenaline—ADRB2—Signaling Pathways—MMP3—rheumatoid arthritis	3.07e-06	1.24e-05	CbGpPWpGaD
Isoprenaline—ADRB2—Signaling by GPCR—TYK2—rheumatoid arthritis	3.07e-06	1.24e-05	CbGpPWpGaD
Isoprenaline—ADRB3—Signaling Pathways—NOS3—rheumatoid arthritis	3.06e-06	1.24e-05	CbGpPWpGaD
Isoprenaline—MAPK1—Signaling by GPCR—IL2—rheumatoid arthritis	3.06e-06	1.24e-05	CbGpPWpGaD
Isoprenaline—ADRBK1—Signaling Pathways—MMP9—rheumatoid arthritis	3.06e-06	1.24e-05	CbGpPWpGaD
Isoprenaline—MAPK1—Signaling Pathways—C3—rheumatoid arthritis	3.06e-06	1.24e-05	CbGpPWpGaD
Isoprenaline—MAPK1—Disease—NOS3—rheumatoid arthritis	3.05e-06	1.24e-05	CbGpPWpGaD
Isoprenaline—MAPK1—Immune System—CD4—rheumatoid arthritis	3.04e-06	1.23e-05	CbGpPWpGaD
Isoprenaline—ADRBK1—Signaling Pathways—NFKB1—rheumatoid arthritis	3.03e-06	1.23e-05	CbGpPWpGaD
Isoprenaline—PIK3R2—Signaling Pathways—MAPK8—rheumatoid arthritis	3.02e-06	1.23e-05	CbGpPWpGaD
Isoprenaline—ADRB1—Signaling Pathways—PTK2—rheumatoid arthritis	3.02e-06	1.23e-05	CbGpPWpGaD
Isoprenaline—ADRB1—GPCR downstream signaling—CXCL8—rheumatoid arthritis	3.01e-06	1.22e-05	CbGpPWpGaD
Isoprenaline—PIK3R2—Immune System—IL6—rheumatoid arthritis	2.99e-06	1.21e-05	CbGpPWpGaD
Isoprenaline—ADRBK1—Signaling Pathways—MAPK8—rheumatoid arthritis	2.98e-06	1.21e-05	CbGpPWpGaD
Isoprenaline—PIK3R1—Disease—TGFB1—rheumatoid arthritis	2.96e-06	1.2e-05	CbGpPWpGaD
Isoprenaline—ADRB1—Signaling Pathways—CCL5—rheumatoid arthritis	2.96e-06	1.2e-05	CbGpPWpGaD
Isoprenaline—ADRB2—Signaling Pathways—PTK2—rheumatoid arthritis	2.95e-06	1.2e-05	CbGpPWpGaD
Isoprenaline—ADRB2—GPCR downstream signaling—CXCL8—rheumatoid arthritis	2.94e-06	1.19e-05	CbGpPWpGaD
Isoprenaline—ADRBK1—Immune System—IL6—rheumatoid arthritis	2.94e-06	1.19e-05	CbGpPWpGaD
Isoprenaline—ADRB1—Signaling Pathways—CSF2—rheumatoid arthritis	2.92e-06	1.18e-05	CbGpPWpGaD
Isoprenaline—CYP1A1—Metabolism of lipids and lipoproteins—PTGS2—rheumatoid arthritis	2.91e-06	1.18e-05	CbGpPWpGaD
Isoprenaline—ADRB2—Signaling Pathways—CCL5—rheumatoid arthritis	2.9e-06	1.17e-05	CbGpPWpGaD
Isoprenaline—ADRB1—GPCR downstream signaling—IL2—rheumatoid arthritis	2.87e-06	1.17e-05	CbGpPWpGaD
Isoprenaline—ADRB2—Signaling Pathways—CSF2—rheumatoid arthritis	2.85e-06	1.16e-05	CbGpPWpGaD
Isoprenaline—MAPK1—Signaling Pathways—LEP—rheumatoid arthritis	2.85e-06	1.16e-05	CbGpPWpGaD
Isoprenaline—MAPK1—Innate Immune System—IL6—rheumatoid arthritis	2.82e-06	1.15e-05	CbGpPWpGaD
Isoprenaline—ADRB2—GPCR downstream signaling—IL2—rheumatoid arthritis	2.81e-06	1.14e-05	CbGpPWpGaD
Isoprenaline—MAPK1—Immune System—IL1B—rheumatoid arthritis	2.81e-06	1.14e-05	CbGpPWpGaD
Isoprenaline—MAPK1—Disease—CD4—rheumatoid arthritis	2.81e-06	1.14e-05	CbGpPWpGaD
Isoprenaline—MAPK1—Immune System—IL2—rheumatoid arthritis	2.8e-06	1.13e-05	CbGpPWpGaD
Isoprenaline—PIK3R2—Signaling Pathways—VEGFA—rheumatoid arthritis	2.79e-06	1.13e-05	CbGpPWpGaD
Isoprenaline—MAPK1—Disease—PTGS2—rheumatoid arthritis	2.79e-06	1.13e-05	CbGpPWpGaD
Isoprenaline—PIK3R1—Signaling Pathways—CXCL8—rheumatoid arthritis	2.78e-06	1.13e-05	CbGpPWpGaD
Isoprenaline—PIK3R2—Disease—IL6—rheumatoid arthritis	2.76e-06	1.12e-05	CbGpPWpGaD
Isoprenaline—ADRBK1—Signaling Pathways—VEGFA—rheumatoid arthritis	2.75e-06	1.12e-05	CbGpPWpGaD
Isoprenaline—ADRB1—Signaling Pathways—SPP1—rheumatoid arthritis	2.74e-06	1.11e-05	CbGpPWpGaD
Isoprenaline—ADRB1—Signaling by GPCR—CXCL8—rheumatoid arthritis	2.73e-06	1.11e-05	CbGpPWpGaD
Isoprenaline—ADRB3—Signaling Pathways—CXCL8—rheumatoid arthritis	2.72e-06	1.1e-05	CbGpPWpGaD
Isoprenaline—ADRBK1—Disease—IL6—rheumatoid arthritis	2.72e-06	1.1e-05	CbGpPWpGaD
Isoprenaline—MAPK1—Signaling Pathways—FN1—rheumatoid arthritis	2.69e-06	1.09e-05	CbGpPWpGaD
Isoprenaline—ADRB2—Signaling Pathways—SPP1—rheumatoid arthritis	2.68e-06	1.09e-05	CbGpPWpGaD
Isoprenaline—MAPK1—Signaling Pathways—IL6ST—rheumatoid arthritis	2.68e-06	1.08e-05	CbGpPWpGaD
Isoprenaline—ADRB2—Signaling by GPCR—CXCL8—rheumatoid arthritis	2.67e-06	1.08e-05	CbGpPWpGaD
Isoprenaline—ADRB1—Signaling Pathways—CCR5—rheumatoid arthritis	2.67e-06	1.08e-05	CbGpPWpGaD
Isoprenaline—PIK3R1—Signaling Pathways—IL2—rheumatoid arthritis	2.66e-06	1.08e-05	CbGpPWpGaD
Isoprenaline—PIK3R1—Signaling by GPCR—IL6—rheumatoid arthritis	2.65e-06	1.07e-05	CbGpPWpGaD
Isoprenaline—PIK3R3—Signaling Pathways—TP53—rheumatoid arthritis	2.65e-06	1.07e-05	CbGpPWpGaD
Isoprenaline—ADRB1—Signaling Pathways—IL2RA—rheumatoid arthritis	2.63e-06	1.07e-05	CbGpPWpGaD
Isoprenaline—MAPK1—Immune System—NFKB1—rheumatoid arthritis	2.62e-06	1.06e-05	CbGpPWpGaD
Isoprenaline—ADRB2—Signaling Pathways—CCR5—rheumatoid arthritis	2.61e-06	1.06e-05	CbGpPWpGaD
Isoprenaline—ADRB1—Signaling by GPCR—IL2—rheumatoid arthritis	2.61e-06	1.06e-05	CbGpPWpGaD
Isoprenaline—ADRB1—Signaling Pathways—C3—rheumatoid arthritis	2.61e-06	1.06e-05	CbGpPWpGaD
Isoprenaline—ADRB3—Signaling Pathways—IL2—rheumatoid arthritis	2.6e-06	1.05e-05	CbGpPWpGaD
Isoprenaline—ADRB3—Signaling by GPCR—IL6—rheumatoid arthritis	2.58e-06	1.05e-05	CbGpPWpGaD
Isoprenaline—MAPK1—Immune System—MAPK8—rheumatoid arthritis	2.58e-06	1.04e-05	CbGpPWpGaD
Isoprenaline—MAPK1—Signaling Pathways—CD80—rheumatoid arthritis	2.58e-06	1.04e-05	CbGpPWpGaD
Isoprenaline—ADRB2—Signaling Pathways—IL2RA—rheumatoid arthritis	2.57e-06	1.04e-05	CbGpPWpGaD
Isoprenaline—PIK3R2—Signaling Pathways—TGFB1—rheumatoid arthritis	2.56e-06	1.04e-05	CbGpPWpGaD
Isoprenaline—ADRB2—Signaling by GPCR—IL2—rheumatoid arthritis	2.55e-06	1.04e-05	CbGpPWpGaD
Isoprenaline—ADRB2—Signaling Pathways—C3—rheumatoid arthritis	2.55e-06	1.03e-05	CbGpPWpGaD
Isoprenaline—ADRBK1—Signaling Pathways—TGFB1—rheumatoid arthritis	2.52e-06	1.02e-05	CbGpPWpGaD
Isoprenaline—PIK3R1—Signaling Pathways—MMP9—rheumatoid arthritis	2.52e-06	1.02e-05	CbGpPWpGaD
Isoprenaline—PIK3R1—Signaling Pathways—NFKB1—rheumatoid arthritis	2.49e-06	1.01e-05	CbGpPWpGaD
Isoprenaline—ADRB3—Signaling Pathways—MMP9—rheumatoid arthritis	2.46e-06	9.97e-06	CbGpPWpGaD
Isoprenaline—PIK3R1—Signaling Pathways—MAPK8—rheumatoid arthritis	2.45e-06	9.93e-06	CbGpPWpGaD
Isoprenaline—MAPK1—Signaling Pathways—POMC—rheumatoid arthritis	2.45e-06	9.92e-06	CbGpPWpGaD
Isoprenaline—ADRB3—Signaling Pathways—NFKB1—rheumatoid arthritis	2.43e-06	9.86e-06	CbGpPWpGaD
Isoprenaline—CYP1A1—Metabolism—CAT—rheumatoid arthritis	2.43e-06	9.86e-06	CbGpPWpGaD
Isoprenaline—ADRB1—Signaling Pathways—LEP—rheumatoid arthritis	2.43e-06	9.84e-06	CbGpPWpGaD
Isoprenaline—PIK3R3—Signaling Pathways—IL6—rheumatoid arthritis	2.42e-06	9.82e-06	CbGpPWpGaD
Isoprenaline—PIK3R1—Immune System—IL6—rheumatoid arthritis	2.42e-06	9.81e-06	CbGpPWpGaD
Isoprenaline—MAPK1—Signaling Pathways—CCL2—rheumatoid arthritis	2.39e-06	9.71e-06	CbGpPWpGaD
Isoprenaline—ADRB3—Signaling Pathways—MAPK8—rheumatoid arthritis	2.39e-06	9.7e-06	CbGpPWpGaD
Isoprenaline—MAPK1—Signaling Pathways—IL6R—rheumatoid arthritis	2.39e-06	9.68e-06	CbGpPWpGaD
Isoprenaline—ADRB2—Signaling Pathways—LEP—rheumatoid arthritis	2.37e-06	9.63e-06	CbGpPWpGaD
Isoprenaline—ADRB1—Signaling Pathways—FN1—rheumatoid arthritis	2.29e-06	9.28e-06	CbGpPWpGaD
Isoprenaline—ADRB1—Signaling Pathways—IL6ST—rheumatoid arthritis	2.28e-06	9.25e-06	CbGpPWpGaD
Isoprenaline—PIK3R1—Signaling Pathways—VEGFA—rheumatoid arthritis	2.26e-06	9.17e-06	CbGpPWpGaD
Isoprenaline—ADRB2—Signaling Pathways—FN1—rheumatoid arthritis	2.24e-06	9.08e-06	CbGpPWpGaD
Isoprenaline—PIK3R1—Disease—IL6—rheumatoid arthritis	2.23e-06	9.06e-06	CbGpPWpGaD
Isoprenaline—ADRB2—Signaling Pathways—IL6ST—rheumatoid arthritis	2.23e-06	9.05e-06	CbGpPWpGaD
Isoprenaline—ADRB3—Signaling Pathways—VEGFA—rheumatoid arthritis	2.21e-06	8.95e-06	CbGpPWpGaD
Isoprenaline—ADRB1—Signaling Pathways—CD80—rheumatoid arthritis	2.19e-06	8.9e-06	CbGpPWpGaD
Isoprenaline—MAPK1—Signaling Pathways—TYK2—rheumatoid arthritis	2.17e-06	8.82e-06	CbGpPWpGaD
Isoprenaline—ADRB2—Signaling Pathways—CD80—rheumatoid arthritis	2.15e-06	8.71e-06	CbGpPWpGaD
Isoprenaline—MAPK1—Signaling Pathways—NOS3—rheumatoid arthritis	2.13e-06	8.65e-06	CbGpPWpGaD
Isoprenaline—PIK3R2—Signaling Pathways—TP53—rheumatoid arthritis	2.11e-06	8.55e-06	CbGpPWpGaD
Isoprenaline—ADRB1—Signaling Pathways—POMC—rheumatoid arthritis	2.09e-06	8.46e-06	CbGpPWpGaD
Isoprenaline—ADRBK1—Signaling Pathways—TP53—rheumatoid arthritis	2.08e-06	8.43e-06	CbGpPWpGaD
Isoprenaline—PIK3R1—Signaling Pathways—TGFB1—rheumatoid arthritis	2.08e-06	8.42e-06	CbGpPWpGaD
Isoprenaline—ADRB1—Signaling Pathways—CCL2—rheumatoid arthritis	2.04e-06	8.27e-06	CbGpPWpGaD
Isoprenaline—ADRB2—Signaling Pathways—POMC—rheumatoid arthritis	2.04e-06	8.27e-06	CbGpPWpGaD
Isoprenaline—ADRB1—Signaling Pathways—IL6R—rheumatoid arthritis	2.03e-06	8.25e-06	CbGpPWpGaD
Isoprenaline—CYP1A1—Metabolism—MTHFR—rheumatoid arthritis	2.03e-06	8.23e-06	CbGpPWpGaD
Isoprenaline—ADRB3—Signaling Pathways—TGFB1—rheumatoid arthritis	2.03e-06	8.22e-06	CbGpPWpGaD
Isoprenaline—MAPK1—Disease—TGFB1—rheumatoid arthritis	2.01e-06	8.17e-06	CbGpPWpGaD
Isoprenaline—ADRB2—Signaling Pathways—CCL2—rheumatoid arthritis	2e-06	8.09e-06	CbGpPWpGaD
Isoprenaline—ADRB2—Signaling Pathways—IL6R—rheumatoid arthritis	1.99e-06	8.07e-06	CbGpPWpGaD
Isoprenaline—PIK3R2—Signaling Pathways—IL6—rheumatoid arthritis	1.93e-06	7.83e-06	CbGpPWpGaD
Isoprenaline—ADRBK1—Signaling Pathways—IL6—rheumatoid arthritis	1.9e-06	7.71e-06	CbGpPWpGaD
Isoprenaline—MAPK1—Signaling Pathways—CXCL8—rheumatoid arthritis	1.89e-06	7.68e-06	CbGpPWpGaD
Isoprenaline—ADRB1—Signaling Pathways—TYK2—rheumatoid arthritis	1.85e-06	7.51e-06	CbGpPWpGaD
Isoprenaline—ADRB1—Signaling Pathways—NOS3—rheumatoid arthritis	1.82e-06	7.38e-06	CbGpPWpGaD
Isoprenaline—ADRB2—Signaling Pathways—TYK2—rheumatoid arthritis	1.81e-06	7.35e-06	CbGpPWpGaD
Isoprenaline—MAPK1—Signaling Pathways—IL2—rheumatoid arthritis	1.81e-06	7.34e-06	CbGpPWpGaD
Isoprenaline—MAPK1—Signaling by GPCR—IL6—rheumatoid arthritis	1.8e-06	7.3e-06	CbGpPWpGaD
Isoprenaline—ADRB2—Signaling Pathways—NOS3—rheumatoid arthritis	1.78e-06	7.21e-06	CbGpPWpGaD
Isoprenaline—MAPK1—Signaling Pathways—MMP9—rheumatoid arthritis	1.71e-06	6.94e-06	CbGpPWpGaD
Isoprenaline—PIK3R1—Signaling Pathways—TP53—rheumatoid arthritis	1.71e-06	6.93e-06	CbGpPWpGaD
Isoprenaline—MAPK1—Signaling Pathways—NFKB1—rheumatoid arthritis	1.69e-06	6.87e-06	CbGpPWpGaD
Isoprenaline—ADRB3—Signaling Pathways—TP53—rheumatoid arthritis	1.67e-06	6.76e-06	CbGpPWpGaD
Isoprenaline—MAPK1—Signaling Pathways—MAPK8—rheumatoid arthritis	1.67e-06	6.75e-06	CbGpPWpGaD
Isoprenaline—MAPK1—Immune System—IL6—rheumatoid arthritis	1.64e-06	6.67e-06	CbGpPWpGaD
Isoprenaline—CYP1A1—Metabolism—POMC—rheumatoid arthritis	1.62e-06	6.58e-06	CbGpPWpGaD
Isoprenaline—ADRB1—Signaling Pathways—CXCL8—rheumatoid arthritis	1.61e-06	6.54e-06	CbGpPWpGaD
Isoprenaline—ADRB2—Signaling Pathways—CXCL8—rheumatoid arthritis	1.58e-06	6.4e-06	CbGpPWpGaD
Isoprenaline—PIK3R1—Signaling Pathways—IL6—rheumatoid arthritis	1.56e-06	6.34e-06	CbGpPWpGaD
Isoprenaline—ADRB1—Signaling Pathways—IL2—rheumatoid arthritis	1.54e-06	6.25e-06	CbGpPWpGaD
Isoprenaline—MAPK1—Signaling Pathways—VEGFA—rheumatoid arthritis	1.54e-06	6.23e-06	CbGpPWpGaD
Isoprenaline—ADRB1—Signaling by GPCR—IL6—rheumatoid arthritis	1.53e-06	6.22e-06	CbGpPWpGaD
Isoprenaline—ADRB3—Signaling Pathways—IL6—rheumatoid arthritis	1.53e-06	6.19e-06	CbGpPWpGaD
Isoprenaline—MAPK1—Disease—IL6—rheumatoid arthritis	1.52e-06	6.16e-06	CbGpPWpGaD
Isoprenaline—ADRB2—Signaling Pathways—IL2—rheumatoid arthritis	1.51e-06	6.12e-06	CbGpPWpGaD
Isoprenaline—ADRB2—Signaling by GPCR—IL6—rheumatoid arthritis	1.5e-06	6.09e-06	CbGpPWpGaD
Isoprenaline—CYP1A1—Metabolism—ALB—rheumatoid arthritis	1.48e-06	6e-06	CbGpPWpGaD
Isoprenaline—ADRB1—Signaling Pathways—MMP9—rheumatoid arthritis	1.46e-06	5.92e-06	CbGpPWpGaD
Isoprenaline—ADRB1—Signaling Pathways—NFKB1—rheumatoid arthritis	1.44e-06	5.85e-06	CbGpPWpGaD
Isoprenaline—ADRB2—Signaling Pathways—MMP9—rheumatoid arthritis	1.43e-06	5.79e-06	CbGpPWpGaD
Isoprenaline—ADRB1—Signaling Pathways—MAPK8—rheumatoid arthritis	1.42e-06	5.75e-06	CbGpPWpGaD
Isoprenaline—CYP1A1—Metabolism—NOS3—rheumatoid arthritis	1.42e-06	5.74e-06	CbGpPWpGaD
Isoprenaline—ADRB2—Signaling Pathways—NFKB1—rheumatoid arthritis	1.41e-06	5.73e-06	CbGpPWpGaD
Isoprenaline—MAPK1—Signaling Pathways—TGFB1—rheumatoid arthritis	1.41e-06	5.72e-06	CbGpPWpGaD
Isoprenaline—ADRB2—Signaling Pathways—MAPK8—rheumatoid arthritis	1.39e-06	5.63e-06	CbGpPWpGaD
Isoprenaline—ADRB1—Signaling Pathways—VEGFA—rheumatoid arthritis	1.31e-06	5.31e-06	CbGpPWpGaD
Isoprenaline—CYP1A1—Metabolism—PTGS2—rheumatoid arthritis	1.29e-06	5.25e-06	CbGpPWpGaD
Isoprenaline—ADRB2—Signaling Pathways—VEGFA—rheumatoid arthritis	1.28e-06	5.2e-06	CbGpPWpGaD
Isoprenaline—ADRB1—Signaling Pathways—TGFB1—rheumatoid arthritis	1.2e-06	4.88e-06	CbGpPWpGaD
Isoprenaline—ADRB2—Signaling Pathways—TGFB1—rheumatoid arthritis	1.18e-06	4.77e-06	CbGpPWpGaD
Isoprenaline—MAPK1—Signaling Pathways—TP53—rheumatoid arthritis	1.16e-06	4.71e-06	CbGpPWpGaD
Isoprenaline—MAPK1—Signaling Pathways—IL6—rheumatoid arthritis	1.06e-06	4.31e-06	CbGpPWpGaD
Isoprenaline—ADRB1—Signaling Pathways—TP53—rheumatoid arthritis	9.9e-07	4.01e-06	CbGpPWpGaD
Isoprenaline—ADRB2—Signaling Pathways—TP53—rheumatoid arthritis	9.68e-07	3.93e-06	CbGpPWpGaD
Isoprenaline—ADRB1—Signaling Pathways—IL6—rheumatoid arthritis	9.06e-07	3.67e-06	CbGpPWpGaD
Isoprenaline—ADRB2—Signaling Pathways—IL6—rheumatoid arthritis	8.86e-07	3.59e-06	CbGpPWpGaD
